Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 2, 1997

View Archived Issues

Spotlight on fibrinogen antagonists

Ranitidine shows no benefit in psoriasis

Anti-IgE antibody inhibits allergen-induced EAR

ET antagonists for asthma

Neuroprotection with new lipid peroxidation inhibitor from Lilly

Clinical results reported for Senetek's Kinetin

Orally active RARgamma-specific retinoid with selective skin effects

Development update on Oncolym

New therapeutic action of aspirin reported by British researchers

Milrinone analogues as novel inotropic agents

Final results of BENESTENT-II trial presented

Novel antimicrobial agents discovered by Ortho

New inhibitors of platelet aggregation from Taiwan

New MMP and TNF inhibitor from Kanebo

TNT nears clinical trials

WHO endorses HIV test

Quadrant licenses platelet technology to Pall

Zambon discovers potent and selective NEP inhibitors

U.S. clearance for Femara

Link between high blood pressure and cancer debated

Reteplase is superior to alteplase in pulmonary embolism

Gene therapy for cardiovascular diseases

HRT and cardiovascular disease in women

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
GWAS identifies variant associated with diabetic retinopathy and susceptibility to T2D
BioWorld Science
Scientists at the University of Nottingham Ningbo China and collaborators aimed to identify genetic variants associated with diabetic retinopathy.